Results new Alzheimer’s drug ‘historic’, also concerns about side effects | Science


Doctors have called the results of a trial of the new Alzheimer’s drug Lecanemab “historic and hopeful”. They don’t think it’s a panacea, but they see the fact that a drug has succeeded in slowing down the brain’s decline as a major breakthrough.

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.